RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement …

Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement …

Add to Collection
Clinical Guidelines and Recommendations SM Devlin, B Bressler, CN Bernstein… - Canadian Journal …, 2013 - downloads.hindawi.com

Chapter : Section17
Journal Year : 2013
Cited by : 40

… In addition, another biosimilar infliximab has been developed by an Indian pharmaceutical … of private payers has begun to affect clinical decision making because adalimumab has been …..... Read More

Keywords : ['subsequent entry biologic', 'inflammatory bowel disease', 'gastroenterology position statement', 'canadian association', 'overview', 'management']
PubMed Link : https://downloads.hindawi.com/journals/cjgh/2013/327120.pdf
Google Scholar Link : https://scholar.google.com/scholar?cites=10281134690582796690&as_sdt=20000005&sciodt=0,21&hl=en&num=20